Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery (Q34218166)

31 July 2017

1 reference

title

Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery (English)

1 reference

31 July 2017

1 reference

1 reference

R Ramajayam

1

1 reference

31 July 2017

Kian-Pin Tan

series ordinal

2

1 reference

31 July 2017

Po-Huang Liang

series ordinal

3

1 reference

31 July 2017

publication date

1 October 2011

1 reference

Biochemical Society Transactions

31 July 2017

published in

1 reference

31 July 2017

volume

39

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

1371-1375

1 reference

Incubation periods of acute respiratory viral infections: a systematic review.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Characterization and inhibition of SARS-coronavirus main protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Mechanism of the maturation process of SARS-CoV 3CL protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Small molecules targeting severe acute respiratory syndrome human coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391371

21 January 2018

Identifiers

DOI

10.1042/BST0391371

1 reference

31 July 2017

1 reference